Pharmaceutical

111, Inc. Announces Third Quarter 2024 Unaudited Financial Results

Maintained Operational Profitability for the Third Consecutive QuarterOperating Expenses as a Percentage of Revenues Decreased 160 Basis Points YoYHeld Positive Operating…

4 weeks ago

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference

RANCHO CUCAMONGA, CA / ACCESSWIRE / November 26, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO,…

4 weeks ago

My Compounding of Brisbane Now Offers Compounding Services Across Australia

BRISBANE, AUSTRALIA / ACCESSWIRE / November 26, 2024 / The healthcare landscape in Australia has taken a significant stride forward…

4 weeks ago

Leading Allergan Trainer Dr. Rubinstein Selected for FDA-Approved BOTOX(R) Cosmetic Treatment of Platysma Bands in Montvale, NJ

Renowned Facial Plastic Surgeon Dr. Rubinstein has been selected to train professionals on FDA-approved BOTOX® Cosmetic for neck rejuvenation in…

4 weeks ago

HIMSS Global Health Conference & Exhibition Wins Prestigious Marketing Awards

ORLANDO, Fla., Nov. 26, 2024 /PRNewswire/ -- Informa Markets and the Healthcare Information and Management Systems Society (HIMSS) proudly announce…

4 weeks ago

COPILOT PROUDLY ANNOUNCES THE RETURN OF ANNE CHIOTTI AS EXECUTIVE PHARMACIST

"Veteran Pharmacist Anne Chiotti Rejoins COPILOT as Executive Pharmacist" SCOTTSDALE, Ariz., Nov. 26, 2024 /PRNewswire/ -- COPILOT Provider Support Services, LLC,…

4 weeks ago

Embr Labs Awarded Six Patents for AI-driven Digital Therapeutics

BOSTON, Nov. 26, 2024 /PRNewswire/ -- Embr Labs, the leader in thermal wellness technology, announces the granting and allowance of…

4 weeks ago

Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients

Research to be presented in a joint poster session with Labcorp at the 2024 San Antonio Breast Cancer Symposium BOSTON…

4 weeks ago

Taglich Brothers Releases Updated Coverage on Cosmos Health: Projects Positive EPS for 2025 and Sets $3 Price Target, Nearly 300% Above Current Share Price

CHICAGO, IL / ACCESSWIRE / November 26, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

4 weeks ago

Revolutionizing Healthcare: Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs

Semaglutide being investigated for applications in heart disease, Alzheimer's, liver disease, and moreGLP-1 drugs expected to generate multi-hundreds of billions…

4 weeks ago